NO951932L - Behandling av infertilitet og forökning av fertiliseringskapasiteter - Google Patents

Behandling av infertilitet og forökning av fertiliseringskapasiteter

Info

Publication number
NO951932L
NO951932L NO951932A NO951932A NO951932L NO 951932 L NO951932 L NO 951932L NO 951932 A NO951932 A NO 951932A NO 951932 A NO951932 A NO 951932A NO 951932 L NO951932 L NO 951932L
Authority
NO
Norway
Prior art keywords
infertility
fertilization
capacities
treatment
increase
Prior art date
Application number
NO951932A
Other languages
English (en)
Other versions
NO320944B1 (no
NO951932D0 (no
Inventor
Rajesh K Naz
Allan L Goldstein
Original Assignee
Washington University Medical
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University Medical, Einstein Coll Med filed Critical Washington University Medical
Publication of NO951932L publication Critical patent/NO951932L/no
Publication of NO951932D0 publication Critical patent/NO951932D0/no
Publication of NO320944B1 publication Critical patent/NO320944B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19951932A 1992-11-17 1995-05-16 Sammensetning, fremgangsmate og anvendelse av thymosinpolypeptider for behandling av infertilitet og forokning av fertiliseringskapasiteten til menn. NO320944B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97785192A 1992-11-17 1992-11-17
PCT/US1993/010620 WO1994012144A2 (en) 1992-11-17 1993-11-05 Treatment of infertility and enhancement of fertilization capacity in mammalian males

Publications (3)

Publication Number Publication Date
NO951932L true NO951932L (no) 1995-05-16
NO951932D0 NO951932D0 (no) 1995-05-16
NO320944B1 NO320944B1 (no) 2006-02-20

Family

ID=25525581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19951932A NO320944B1 (no) 1992-11-17 1995-05-16 Sammensetning, fremgangsmate og anvendelse av thymosinpolypeptider for behandling av infertilitet og forokning av fertiliseringskapasiteten til menn.

Country Status (16)

Country Link
US (1) US5585234A (no)
EP (1) EP0668876B1 (no)
JP (1) JP3989531B2 (no)
KR (1) KR100298858B1 (no)
CN (1) CN1153589C (no)
AU (1) AU679952B2 (no)
CA (1) CA2148689C (no)
DE (1) DE69330884T2 (no)
DK (1) DK0668876T3 (no)
ES (1) ES2164696T3 (no)
FI (1) FI113007B (no)
NO (1) NO320944B1 (no)
PH (1) PH31119A (no)
TW (1) TW234692B (no)
WO (1) WO1994012144A2 (no)
ZA (1) ZA938599B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5873298A (en) * 1998-06-23 1999-02-23 Chang; Kwei-Tang Dual-function filter type pot cover
US20030135876A1 (en) * 2002-01-16 2003-07-17 Larry Mobraaten Maintenance of genetic lines using cryopreserved sperm
IT201900016319A1 (it) * 2019-09-13 2021-03-13 Luigina Romani Timosina alfa 1 per l’uso nel trattamento dell’infertilità maschile da esposizione a metalli pesanti.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
US4950590A (en) * 1986-01-13 1990-08-21 Board Of Governors Of Wayne State University Method and kit for assay for measurement of serum thymosin alpha1

Also Published As

Publication number Publication date
AU679952B2 (en) 1997-07-17
NO320944B1 (no) 2006-02-20
EP0668876A1 (en) 1995-08-30
CA2148689C (en) 1998-12-29
ES2164696T3 (es) 2002-03-01
WO1994012144A2 (en) 1994-06-09
DK0668876T3 (da) 2001-12-03
FI952381A0 (fi) 1995-05-16
TW234692B (no) 1994-11-21
KR950703984A (ko) 1995-11-17
DE69330884T2 (de) 2002-06-06
FI113007B (fi) 2004-02-27
FI952381A (fi) 1995-07-11
JP3989531B2 (ja) 2007-10-10
PH31119A (en) 1998-02-23
NO951932D0 (no) 1995-05-16
KR100298858B1 (ko) 2001-11-14
ZA938599B (en) 1994-06-28
DE69330884D1 (de) 2001-11-08
CN1112444A (zh) 1995-11-29
JPH08503705A (ja) 1996-04-23
EP0668876B1 (en) 2001-10-04
US5585234A (en) 1996-12-17
CA2148689A1 (en) 1994-06-09
AU5592194A (en) 1994-06-22
WO1994012144A3 (en) 1994-07-21
CN1153589C (zh) 2004-06-16

Similar Documents

Publication Publication Date Title
NO174492C (no) Fremgangsmåte og installasjon for behandling av væske
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO974365D0 (no) Fremgangsmåte og krystallformer av 2-metyl-thieno-benzodiazepin
NO940277D0 (no) Triglycerider og blandinger av slike
NO175801C (no) Gjentatt formbart flerlags fottöy og anvendelse av et slikt fottöy
NO960552D0 (no) Elektrode og fremstilling av elektroden
NO920780D0 (no) Fremgangsmaate og anordning for behandling av epilepsi
NO943353D0 (no) Kombinasjoner av ACE-inhibitorer og diuretiske midler
NO971900D0 (no) Blandinger og behandling av multippel sklerose
NO965563D0 (no) Behandling og profylakse av osteoporese
NO881322L (no) Fremgangsmaate og anlegg for behandling av returnert boreslam.
NO924704L (no) Medikamenter for behandling av betennelsestilstander og for analgesi
NO931779L (no) Fremgangsmåte for behandling av kondensater av ammoniakk og urea
NO177731C (no) F¶rprodukt og fremgangsmÕte for fremstilling av samme
NO931945D0 (no) Fremgangsmaate og system for signalbehandling
NO951932L (no) Behandling av infertilitet og forökning av fertiliseringskapasiteter
NO961747D0 (no) Behandling av reumatoid artritt
NO307080B1 (no) Fremgangsmåte for fremstilling av katalysatorer og anvendelse derav
NO924390D0 (no) Fremgangsmaate og system for fremskaffelse av volumgjengivelse
NO923799L (no) Behandling av korn
NO973659D0 (no) Anvendelse av LCK SH2-spesifikke forbindelser til behandling av autoimmune sykdommer og transplantatavvisning
NO953674D0 (no) Etylen-propylen-kopolymer og fremgangsmåte for fremstilling av slik
NO933076L (no) Næringssammensetning og fremgangsmåte for fremstilling
NO950778D0 (no) Kloning og ekspresjon av
NO920262D0 (no) Svinefortilsetning og svinefor inneholdende tilsetningen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees